9/21/2020, 12:53 PM (Source: TeleTrader)
more TeleTrader news

Illumina to buy Grail for $7.1 billion - report

Illumina Inc. is looking to acquire Grail Inc. for $7.1 billion, the Wall Street Journal reported on Monday. The company is already a partial owner of Grail, a gene-sequencing company, and is now planning to buy the rest of the stake with $3.1 billion in cash and $4 billion in shares.

The acquisition would give Illumina access to Grail's blood test for early cancer detection, commonly known as liquid biopsy, sources close to the talks said.

Illumina launched Grail as a separate company in 2016.

Baha Breaking News (BBN) / VP